B CAPITAL SERVICES LTD
Company number 06578149 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: B CAPITAL SERVICES LTD
Company No. 06578149 | Incorporated 28 April 2008 | Status: Active | Micro-entity (SIC 82110 — Combined office administrative service activities)
1. Financial Health Score: D (Poor — but stable and small in scale)
Why a D? The company is balance-sheet insolvent: it owes more than it owns. Its net worth has fallen from a peak of £132,155 in 2019 to negative £5,675 in 2025. That is a serious symptom. However, the absolute size of the deficit is tiny (a few thousand pounds), the company is still active, not in liquidation, and all statutory filings are up to date. So this is best described as a chronic, low-grade condition in a very small patient — not an acute emergency, but not healthy either.
2. Key Vital Signs
| Vital Sign | 2025 | 2024 | 2023 | 2019 (peak) | Interpretation |
|---|---|---|---|---|---|
| Total assets | £10,411 | £0 | £2,206 | £136,391 | 99.9% decline from peak — body mass has wasted away |
| Total liabilities | £16,086 | £332 | £1,038 | £4,236 | Debt load now exceeds assets |
| Net assets (equity) | −£5,675 | −£332 | £1,168 | £132,155 | Negative — technically insolvent |
| Net current assets (working capital) | −£6,487 | −£332 | — | — | Short-term obligations exceed short-term resources |
| Current ratio | 0.60 | n/a | — | — | Below 1.0 = cannot cover near-term bills from current assets |
| Liabilities ÷ assets | 155% | n/a | 47% | 3% | Liabilities are 1.55× assets — over-leveraged |
| Cash (last disclosed) | not shown | not shown | — | £26,364 (2019) | Cash "pulse" no longer visible in filings |
| Employees | 2 | 1 | — | — | Slight re-activation of activity |
| Share capital | £1 | £1 | £1 | £1 | Nominal — no capital buffer |
| Filing compliance | Current | Current | — | — | Good hygiene: no overdue accounts or confirmation statement |
Vital signs explained in plain English:
- Total assets (£10,411): What the company owns — a small fixed asset (£812) plus current assets (£9,599, likely cash/debtors).
- Total liabilities (£16,086): What it owes within a year. In a micro-entity like this, such balances are frequently director or shareholder loans rather than bank debt — but the filings don't confirm this.
- Net assets (−£5,675): The "net worth." Negative means, on paper, the company would have nothing left if it sold everything and paid its debts.
- Current ratio (0.60): For every £1 of short-term bills, there is only 60p of short-term assets. A ratio below 1.0 is a classic liquidity warning sign.
3. Diagnosis: What the Numbers Reveal
The clinical history tells a clear story:
-
2016–2019 — A robust, well-capitalised patient. The company built up strong reserves: net assets grew from £81,127 (2016) to £132,155 (2019), with healthy cash balances (£26,364 in 2019). This was a financially fit business.
-
2019–2020 — A major "harvesting" event. Total assets collapsed from £136,391 to £3,483 in a single year — a fall of roughly £132,900 (97%). This pattern is consistent with a large distribution (e.g., dividends), transfer of assets, or the business being wound down internally. Whatever happened, the company's wealth left the balance sheet.
-
2020–2023 — Chronic low-grade state. Net assets hovered at trivial levels (£175 to £1,168). The company became, in effect, a near-dormant shell.
-
2024 — Near-total depletion. The balance sheet showed £0 total assets against £332 of liabilities — a fully stripped vehicle.
-
2025 — Faint signs of re-activation, but now insolvent. Fixed assets (£812) and current assets (£9,599) reappeared, employees rose to 2, but creditors jumped to £16,086, pushing net assets to −£5,675.
Underlying business health:
- Solvency: The company fails the standard balance-sheet solvency test (assets < liabilities). This matters legally — it restricts the ability to pay dividends and triggers directors' duties around wrongful trading if the company continues to trade while insolvent.
- Liquidity: Weak — a current ratio of 0.60 means near-term obligations outstrip near-term resources.
- Profitability: Unknown — the directors elected not to file a profit and loss account (permitted for micro-entities under FRS 105). We cannot see whether the company is actually making or losing money. This is a significant blind spot.
- Governance & compliance: Healthy. Filings are current, no overdue accounts, no liquidation, no disqualification flags. The administrative "immune system" is functioning.
- Scale: Very small. The entire deficit is less than £6,000 — immaterial in absolute terms and easily curable.
Important caveat: If the £16,086 of creditors is money owed to the director/shareholder (very common in micro-entities), then the "insolvency" is largely cosmetic — it would disappear if the loan were capitalised or waived. If, however, these are third-party creditors, the situation is more serious.
4. Prognosis: Future Financial Outlook
Short-term (12 months): Stable but fragile. The company is compliant and active, and the deficit is small. There is no imminent threat of formal insolvency proceedings given the trivial sums involved. However, the negative equity position means the company cannot lawfully distribute dividends and directors should be documenting their going-concern reasoning.
Medium-term (1–3 years): Two possible paths:
- Recovery path (likely, if the creditors are related-party loans): A simple capital injection, loan waiver, or capitalisation of director loans would restore positive net assets almost immediately. The company could then trade normally.
- Decline path (if trading continues without correction): Persistent negative equity, combined with any genuine third-party creditors, could expose directors to wrongful trading risk and the company to creditor pressure.
Overall prognosis: Guarded — good, provided the cause of the negative equity is addressed. The underlying "vital organs" (compliance, active status, ownership clarity) are intact; the problem is a depleted balance sheet, not a failing business model.
5. Recommendations: Specific Actions to Improve Financial Wellness
-
Diagnose the creditor composition. Confirm in writing whether the £16,086 owed is to directors/shareholders or to external parties. This single fact determines whether the company is genuinely at risk or merely showing a bookkeeping deficit.
-
Restore positive net assets. Options include: a shareholder capital injection, formal waiver/capitalisation of director loans, or conversion of debt to equity. This clears the technical insolvency and reopens the ability to pay dividends.
-
Document a going-concern assessment. Given negative equity, directors should record their reasoning that the company can meet its obligations for at least 12 months. This protects against wrongful-trading allegations.
-
Reinstate visibility of profitability. Even if a P&L isn't filed publicly, maintain internal management accounts. You cannot manage what you cannot measure — the absence of profit data is the biggest blind spot in this assessment.
-
Review the 2019–2020 asset reduction. Confirm that any distribution of ~£133k was properly authorised, supported by distributable profits at the time, and correctly treated for tax. This is a historical hygiene check that protects against future challenge.
-
Decide the company's purpose. If it is no longer trading meaningfully, consider whether formal dormancy or voluntary dissolution is cleaner than maintaining an insolvent shell. If it is being revived (as the 2025 figures hint), ensure it is adequately capitalised for that purpose.
-
Maintain the good habits. Keep filings current — this is the company's strongest health indicator and should continue.